Sanuwave Health Inc (SNWV) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Sanuwave Health Inc   (NASDAQ: SNWV)
 

Sanuwave Health Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Sanuwave Health Inc 's inventory turnover ratio sequentially decreased to 1.62 in the second quarter 2026, unsurprisingly, as the Sanuwave Health Inc markets continue to deteriorate, and SNWV's faces growing challenges to bring down its inventories. Sanuwave Health Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 225 days, from 217 days, in the Mar 31 2026 quarter.

Within Healthcare sector 246 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1655, from total ranking in the first quarter 2026 at 1876.

SNWV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sanuwave Health Inc Market Share?

What is Inventory Turnover Ratio?




SNWV Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 19.61 % 8.17 % 43.02 % 98.6 % 116.44 %
Y / Y Cost of Sales Growth 4.94 % 11.75 % 48.45 % 10.16 % 14.78 %
Inventory Turnover Ratio (TTM) 1.62 1.68 1.67 1.61 1.85
SNWV's Total Ranking # 1655 # 1876 # 1725 # 1646 # 1538
Average inventory processing period 225 217 218 227 198
Seq. Inventory Growth 19.77 % -0.52 % -12.91 % 15.28 % 8.32 %
Seq. Cost of Sales Growth 5.8 % -35.5 % 34.28 % 14.51 % 12.67 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 112
Healthcare Sector # 247
Overall Market # 1655

Inventory Turnover Ratio Statistics
High Average Low
5.04 1.95 0.5
(Jun 30 2023)   (Sep 30 2013)




Financial Statements
Sanuwave Health Inc 's Inventories $ 7 Millions Visit SNWV's Balance sheet
Sanuwave Health Inc 's Cost of Revenues TTM $ 10 Millions Visit SNWV's Income Statement
What are SNWV's Sales? Visit SNWV's Sales by Segment

Other Inventory Turnover Ratios
Sanuwave Health Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SNWV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SNWV's Competitors
Inventory Turnover Ratio for SNWV's Suppliers
Inventory Turnover Ratio for SNWV's Customers

You may also want to know
SNWV's Sales Growth Rates SNWV's Pe Price to earnings ratio SNWV's Receivables Turnover Ratio SNWV's Stock Quote
SNWV's Net Income Growth Rates SNWV's Ps Price to Sales ratio SNWV's Sales per Employee SNWV's Asset Turnover Ratio
SNWV's Net Margin SNWV's Pb Price to Book ratio SNWV's Financial Strength Ratios SNWV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions

Date modified: 2026-09-05T15:32:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.